This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Fibroblast Growth Factor 8 (FGF8), N-His
Product Overview
BioVenic's Recombinant Equine Fibroblast Growth Factor 8 (FGF8), N-His is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 29 kDa. The purity is greater than 90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.
Specifications
Target Information
Fibroblast Growth Factor 8 is encoded by the FGF8 gene in horses. It is a member of the FGF family, which possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10 mM PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.